Atlas FDA

SUPARTZ FX; VISCO-3

FDA premarket approval P980044/S063 · decided 2025-07-22

Approval details

PMA number
P980044
Supplement
S063
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
SUPARTZ FX; VISCO-3
Generic name
Acid, hyaluronic, intraarticular
Applicant
Seikagaku Corp.
Date received
2025-06-30
Decision date
2025-07-22
Days to decision
22 days
Decision code
OK30
Product code
MOZ
Advisory committee
Orthopedic
Expedited review
No
Location
Tokyo
Statement
change to install an automated visual inspection (AVI) system to one line of the in-process inspection line used for the SUPARTZ product family

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
HADGEL, 4 GRAM/SYRINGE (K011544)Seikagaku Corp.2001-08-15